SCHEMBL19081006

SCHEMBL19081006

CC1(C)c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)oc4ccccc45)c4ccccc34)cc2-c2cc3oc4ccc5ccccc5c4c3cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
HCRTR1 O43613 1/20 0.34
PAX8 Q06710 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
AHR P35869 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PGR P06401 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080699 0.91 ABCG2 (0.37) ABCG2TDP1L3MBTL1PAX8NPC1
SCHEMBL19080972 0.90 ABCG2 (0.35) ABCG2TDP1L3MBTL1MEN1MAPT
SCHEMBL19080674 0.90 ABCG2 (0.38) ABCG2TDP1L3MBTL1MEN1MAPT
SCHEMBL19109486 0.89 MEN1 (0.35) TDP1L3MBTL1MEN1MAPTKMT2A
SCHEMBL17931985 0.89 ABCG2 (0.35) ABCG2TDP1L3MBTL1MEN1MAPT
SCHEMBL17851743 0.89 ABCG2 (0.37) ABCG2TDP1MEN1MAPTKMT2A
SCHEMBL19080803 0.88 ABCG2 (0.37) ABCG2TDP1L3MBTL1MEN1KMT2A
SCHEMBL19080966 0.88 ABCG2 (0.35) ABCG2TDP1MEN1MAPTKMT2A
SCHEMBL21729922 0.88 ABCG2 (0.36) ABCG2TDP1L3MBTL1MEN1MAPT
SCHEMBL17944585 0.88 MEN1 (0.38) MEN1MAPTKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885TDP1 2322/4885L3MBTL1 1245/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885TDP1 2322/4885L3MBTL1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.